Nucleai Blog How AI startups working on clinical trials for cancer could find a breakthrough before big pharma

Nucleai is creating AI-driven spatial biomarkers, and uses AI to create a map of cells in biopsy tissue samples that can provide all-important information for a personalised treatment approach. "We couldn't find these relationships using traditional methods, so we started working with Nucleai who had the right tools." "We have developed an AI-driven spatial biology [...]The post How AI startups working on clinical trials for cancer could find a breakthrough before big pharma appeared first on Nucleai.